Arlington, MA, United States of America

Katherine Taylor

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Katherine Taylor: Innovator in CNS Delivery Systems

Introduction

Katherine Taylor is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of medical science, particularly in the development of methods for the delivery of lysosomal enzymes to the central nervous system (CNS). With a total of 4 patents to her name, her work focuses on addressing lysosomal storage diseases, which can have devastating effects on patients.

Latest Patents

Katherine's latest patents include innovative methods and compositions for CNS delivery of arylsulfatase A. One of her notable inventions provides compositions and methods for the effective treatment of lysosomal storage diseases, specifically Metachromatic Leukodystrophy Disease. This invention includes a stable formulation for direct CNS intrathecal administration, comprising an arylsulfatase A (ASA) protein, salt, and a polysorbate surfactant. Another patent focuses on stable formulations for CNS delivery of arylsulfatase A, which includes recombinant human arylsulfatase A (rhASA) for the treatment of lysosomal storage diseases. This formulation is designed for intrathecal administration and ensures that less than 3% of the ASA protein exists in aggregated form.

Career Highlights

Throughout her career, Katherine has worked with leading companies in the pharmaceutical industry. She has been associated with Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. Her work in these organizations has allowed her to contribute to groundbreaking research and development in genetic therapies.

Collaborations

Katherine has collaborated with several professionals in her field, including Nazila Salamat-Miller and Paul Campolieto. These collaborations have further enhanced her research and innovation efforts.

Conclusion

Katherine Taylor is a dedicated inventor whose work in CNS delivery systems has the potential to transform the treatment of lysosomal storage diseases. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…